The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasiaOriginal paper
What was studied?
This study examined how cervical microbiota composition relates to the severity of cervical intraepithelial neoplasia (CIN), distinguishing direct associations from indirect associations mediated through HPV infection. Prior research had only measured the total association between cervical microbiota and either HPV infection or CIN, without separating these two pathways. The researchers used 16S rRNA gene sequencing to profile cervical microbiota and a sensitive PCR method to detect HPV, then modeled direct and indirect (HPV-mediated) associations with CIN status separately.
Who was studied?
The study included 126 women classified as CIN 1- (normal cytology and CIN 1) and 40 women classified as CIN 2+ (CIN 2 and CIN 3), for a total of 166 women. Cervical samples from these women were analyzed for microbiota composition using Illumina sequencing of the 16S rRNA gene, and HPV status was determined using the SPF1/GP6+ PCR primer set.
What were the most important findings?
Several taxa, including Pseudomonas stutzeri, Bacteroides fragilis, Lactobacillus delbrueckii, Atopobium vaginae, and Streptococcus agalactiae, showed indirect associations with CIN status mediated by HPV infection. For Ps. stutzeri, the direct and indirect associations with CIN status ran in opposite directions, while for A. vaginae the direct and indirect associations ran in the same direction. B. fragilis, L. delbrueckii, and S. agalactiae showed only indirect associations with CIN status, with no independent direct effect detected.
What are the greatest implications of this study?
The findings suggest that some cervical microbial populations, including B. fragilis, influence CIN risk primarily by way of their relationship with HPV infection rather than through a direct pathway. Distinguishing direct from HPV-mediated indirect associations offers a more precise picture of how the cervical microbiome contributes to cervical disease progression. This approach could help refine future research into microbiota-based risk assessment or intervention strategies for cervical neoplasia.